{
    "accession": "ENCBS947VKK", 
    "age": "53", 
    "age_units": "year", 
    "biosample_term_id": "EFO:0002067", 
    "biosample_term_name": "K562", 
    "biosample_type": "immortalized cell line", 
    "characterizations": [], 
    "dbxrefs": [
        "Cellosaurus:CVCL_0004"
    ], 
    "description": "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. This K562 growth has been treated with an shRNA against PTBP1", 
    "documents": [
        {
            "attachment": "/documents/24b67f9c-c791-4a2a-a33b-419794e4681a/@@download/attachment/Graveley-K562-growth-protocol.pdf", 
            "document_type": "growth protocol", 
            "references": [], 
            "urls": []
        }, 
        {
            "attachment": "/documents/0225b4b9-6d4d-468b-879c-95cf4ffef01b/@@download/attachment/Graveley-shRNA-transfection-protocol.pdf", 
            "document_type": "transfection protocol", 
            "references": [], 
            "urls": []
        }
    ], 
    "donor": "ENCDO000AAD", 
    "health_status": "chronic myelogenous leukemia (CML)", 
    "lab": "Brenton Graveley, UConn", 
    "life_stage": "adult", 
    "organism": "Homo sapiens", 
    "references": [], 
    "sex": "female", 
    "source": "ATCC", 
    "summary": "Homo sapiens K562 immortalized cell line transiently expressing shRNA targeting PTBP1", 
    "treatments": [], 
    "url": "http://www.atcc.org/Products/All/CCL-243.aspx"
}